SCHEMBL4495622

SCHEMBL4495622

C[C@@]1(c2ccccc2)NC(=O)C=C1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
GAA P10253 2/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
AKR1B1 P15121 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HCAR3 P49019 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
CYP1A2 P05177 1/20 0.37
KDM4E B2RXH2 1/20 0.36
GFER P55789 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
CACNA1F O60840 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
HTR2A P28223 1/20 0.36
HRH1 P35367 1/20 0.36
SCN1A P35498 1/20 0.36
SCN4A P35499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4495628 1.00 ALDH1A1 (0.46) ALDH1A1GAAMMP2MMP9AKR1B1
SCHEMBL4507630 1.00 ALDH1A1 (0.46) ALDH1A1GAAMMP2MMP9AKR1B1
SCHEMBL4509138 0.70 ALDH1A1 (0.39) ALDH1A1MMP2MMP9KDM4EHTT
SCHEMBL542865 0.67 ALDH1A1 (0.59) ALDH1A1MMP2MMP9AKR1B1MEN1
SCHEMBL4384456 0.67 ALDH1A1 (0.59) ALDH1A1MMP2MMP9AKR1B1MEN1
SCHEMBL4384462 0.67 ALDH1A1 (0.59) ALDH1A1MMP2MMP9AKR1B1MEN1
SCHEMBL2984464 0.67 MMP2 (0.48) ALDH1A1MMP2MMP9MEN1KMT2A
SCHEMBL9285876 0.66 ALDH1A1 (0.45) ALDH1A1GAAMMP2MMP9MEN1
SCHEMBL6282916 0.65 ALDH1A1 (0.57) ALDH1A1MMP2MMP9AKR1B1MEN1
SCHEMBL5924523 0.64 ALDH1A1 (0.47) ALDH1A1GAAMMP2MMP9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612099-B2 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-03 US disclosed
EP-1957483-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-08-20 EP disclosed
WO-2007063010-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-07 WO disclosed
US-20070129421-A1 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129421-A1 Vinylogous acid derivatives CMA1, TPSG1, TPSAB1 ALDH1A1 477/4885GAA 4/4885MMP2 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.